Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close

Donate

Incidence & Prevalence in Canada

In 2017, an estimated 2,900 new cases of multiple myeloma will be diagnosed and approximately 1,450 myeloma-associated deaths.
In the period from 2003 to 2012, the annual percentage rate in mortality rate was 0.9% in men and -1.8% in women.
The average age at diagnosis is 62 years for men and 61 years for women, with only 4% of cases diagnosed in individuals under the age of 45.
The incidence of myeloma varies from country to country, from a low of fewer than one per 100,000 people in China, to a high of about four per 100,000 people in most western industrialized countries.

Incidence, prevalence and mortality, what's the difference?

INCIDENCE: The number of new cases diagnosed in a year.
MORTALITY: The number of deaths attributed to cancer.
PREVALENCE: The total number of cases of a disease at a specific time.
Prevalence is influenced by both the incidence and the mortality rate. Prevalence increases when survival rates increase, even though incidence remains the same.
As multiple myeloma patients live longer, the prevalence increases.

Next

We’re here to help.

Join our community and sign up for our newsletter.